Pfizer Secures FDA Approval for Geodon Capsules for Bipolar Disorder in Adults
From M2 Europharma - Nov 23, 2009
Pharmaceutical company Pfizer Inc announced on Friday the receipt of
approval from the FDA for Geodon Capsules for maintenance treatment
of bipolar I disorder in adults. The company said that the FDA
approval is based on the efficacy and safety of Geodon in a
six-month, double-blind, randomized, placebo-controlled trial in
adult patients with bipolar I disorder.
www.peoplewho.org